Article

New LED phototherapy device for skin rejuvenation

Ablative skin rejuvenation procedures often are associated with prolonged healing, and can cause scarring, prolonged erythema, and hyperpigmentation.

Key Points

Some non-ablative procedures such as those using the Q-switched Nd:YAG, long-pulsed ND:YAG, and ER:glass lasers utilize heat energy to cause controlled thermal injury to the dermis. Light-emitting diode (LED) phototherapy is a non-thermal and atraumatic treatment stimulating fibroblast proliferation, collagen synthesis, growth factors, and extracellular matrix production through photo-biomodulation. Previous reports in the medical literature have suggested that LED phototherapy may be beneficial for improving skin tone and facial rhytids, preventing radiation-induced dermatitis, reducing inflammatory lesions in patients with mild-to-severe acne, and enhancing wound healing following ablative skin resurfacing.

A 19-year-old girl was involved in a motor vehicle accident and sustained lacerations to the upper lip and ankle. Twelve months after her injury, she continued to have raised hyperpigmented scars that had been refractory to topical and intralesional corticosteroid injections. After undergoing eight weekly treatments with the combined red/infrared LED phototherapy, moderate flattening and fading of the scars was noted.

Patient 2

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.